Clinical Trial Update: Brain Mets - Capecitabine Plus Sunitinib and WBRT [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating capecitabine plus sunitinib with whole-brain radiotherapy in breast cancer patients with brain metastases was terminated; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Sunitinib (sunitinib)

Snippet

Sponsor: Baylor Breast Care Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-08-12